ER Editor: Our distinct impression here is that once the cabal scumbags are allowed to crumble in public view (they were allegedly taken out quite some time ago, at least at the top-most levels), the good news starts to come out.
Readers may also be interested in this —
Cancer treatment can cause metastasis; a new nutraceutical drug can contain it: Research
From NDTV —
Tata Institute Claims Success In Cancer Treatment – With “Rs 100 Tablet”
Notice the importance of oxyygen and copper —
The Tata Memorial Centre (TMC), in their research, said dying cancer cells release cell-free chromatin particles (cfChPs, or fragments of chromosomes) which can turn healthy cells into cancerous ones. Some of the cfChPs may fuse with healthy chromosomes and cause new tumours.
“To find a solution to this problem, doctors gave pro-oxidant tablets with resveratrol and copper (R+Cu) to the rats,” Dr Badve told NDTV. The R+Cu generate Oxygen radicals, which destroy Chromatin Particles.
The ‘R+Cu’ when taken orally, generate Oxygen radicals in the stomach which are quickly absorbed to enter blood circulation. The oxygen radicals destroy cfChPs released in circulation and prevent ‘Metastases’ – The movement of cancer cells from one part of the body to another. The researchers claimed that R+Cu prevents Chemotherapy toxicity.
The researchers in their presentation called it the “Magic of R+Cu”.
********
India’s $1 pill could be key to curing cancer – report
Researchers at the TATA Institute have developed a medicine that could prevent the recurrence of cancer and reduce the side effects of treatment by 50%
RT
The TATA Institute in Mumbai has developed a pill that could prevent the recurrence of cancer and reduce the side effects of treatment by 50%, the Economic Times reported on Wednesday. The development comes after a decade of research.
.
The new drug, ‘R+Cu’, contains pro-oxidants such as resveratrol and copper which could generate cancer-fighting ‘oxygen radicals’. They prevent dying cells from turning healthy ones cancerous, while also restraining the movement of cancer cells from one part of the body to another, known as ‘metastasis’.
The drug could be effective in treating pancreatic, lung, and oral cancers, researchers have suggested.
The medicine is expected to cost a mere 100 rupees ($1.2) at a time when the price of cancer treatment is soaring. The R+Cu is awaiting approval from the Food Safety and Standards Authority of India (FSSAI), and is likely to be released to the market in June-July.
“The side-effects were tested on both rats and humans, but the prevention test was done only on rats. It will take about five years to complete the human trials for this,” surgeon Dr Rajendra Badve from the Tata Memorial Hospital revealed in the interview with NDTV. He added “there were challenges during the research” but eventually it is “a big success.”
The Tata Memorial Center is amongst the world’s oldest and largest cancer research facilities, and is funded and controlled by India’s Department of Atomic Energy.
The development was reported weeks after Russian President Vladimir Putin claimed that his country is on the cusp of developing anti-cancer vaccines. “We have reached a significant milestone in the development of cancer vaccines and next-generation immunomodulatory drugs,” the Russian leader stated.
India has added 30 new cancer hospitals in the last nine years, and work is underway on ten more, Prime Minister Narendra Modi said last month. The government has also developed 150,000 wellness centers, called ‘Ayushman Arogya Mandirs’, to help the early detection of cancer among rural populations.
India, the most populous nation in the world, has some of the highest cancer rates in Asia, and the disease is seen as a major cause of worry by the government. The number of cases in the country is projected to rise from 1.46 million in 2022 to 1.57 million in 2025, according to the Indian Council of Medical Research-National Cancer Registry Programme.
Source
************
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply